Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ITGAL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | NKIRAS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | IRF4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | SF3B4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ADIPOR1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | NKD2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZNF175 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SH3PXD2A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | GFI1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PAQR3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |